ACR GUIDELINES Bundle (free trial)

ACR Rheumatoid Arthritis RA Guidelines

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/622897

Contents of this Issue

Navigation

Page 9 of 19

8 Treatment Figure 2. Established Rheumatoid Arthritis 2 a Also consider using short-term glucocorticoids (defined as <3 months treatment) for RA disease flares. Glucocorticoids should be used at the lowest possible dose and for the shortest possible duration to provide the best benefit-risk ratio for the patient. b Consider adding low-dose glucocorticoids (≤10 mg/day of prednisone or equivalent) in patients with moderate or high RA disease activity when starting traditional DMARDs and in patients with DMARD failure or biologic failure. Low Disease Activity Moderate or High Disease Activity DMARD Monotherapy a DMARD Monotherapy a Combination Traditional DMARDs a, b or TNF Inhibitor +/- MTX a, b or Non-TNF Biologic +/- MTX a, b or Tofacitinib +/- MTX Treat to Target c Low disease activity, but not remission, continue RA treatments d In remission, consider tapering RA treatments d Moderate or High Disease Activity DMARD-Naïve Established RA Moderate or High Disease Activity a, b Continued on next page

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - ACR Rheumatoid Arthritis RA Guidelines